Speciality Medicines opened higher at ₹167.75, compared with its previous close of ₹161.00. In the last trading session on 12 Nov 2026, the stock traded between ₹167.75 and ₹171.00, with an average traded price of ₹168.92. It showed an upward intraday trend.
An investment of ₹10,000 made 1 year ago in Speciality Medicines is now worth
₹ 13,503.00
Giving a profit of
₹ 3,503.00 (35.03%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
+9.00 (+5.59%)
Day High
₹171.00
Day Low
₹167.75
Day Open
₹167.75
Prev Close
₹161.00
Volume
9,000
Value Traded
₹0.15 Cr
1W Return
25.93%
1M Return
0.89%
3M Return
6.92%
6M Return
-43.29%
1Y Return
35.03%
Market Cap (₹ Cr.)
149
PE Ratio
10.90
PB Ratio
1.99
Dividend Yield
-
ROE
18.31%
ROCE
18.78%
Book Value (₹)
81.03
Face Value (₹)
10.00
EPS (TTM)
-
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
25.93%
6 Weeks
-
1 Month
0.89%
3 Months
6.92%
9 Months
35.03%
No data available.
Speciality Medicines H1FY27 Results: Net profit up 83% YoY to ₹888 lakh
Revenue from operations surged 185% YoY to ₹8,695.10 lakh in H1FY27. Net profit increased 83% YoY to ₹888.49 lakh, with EPS at ₹10.11. Operating cash flow turned negative at ₹327.41 lakh due to inventory buildup. IPO proceeds of ₹1,795.09 lakh utilized as of September 30, 2026.
TodaySpeciality Medicines closes trading window ahead of Q2FY27 results
Trading window closed from October 1, 2026. Restriction lasts until 48 hours after Q2FY27 results. Compliance with SEBI Insider Trading Regulations 2015. Applies to insiders under company code of conduct.
1mo agoSpeciality Medicines passes all resolutions at fifth annual general meeting
All resolutions at Speciality Medicines' 5th AGM passed with 100% votes in favor. Total votes polled stood at 5,534,760 with zero votes against or invalid. Promoter group voted 99.08% of held shares, while public non-institutions voted 35.29%. Meeting held virtually on September 28, 2026, with 13 shareholders attending via video conferencing.
1mo agoSpeciality Medicines sets Sept 28 AGM, opens remote e-voting
Fifth AGM scheduled for September 28, 2026, via video conferencing. Remote e-voting window runs from September 25 to September 27, 2026. Cut-off date for voting eligibility is September 21, 2026. Sumit Goyani seeks reappointment as Whole-Time Director by rotation.
2mo agoSpeciality Medicines secures regulatory approval for two new products in Ethiopia
Speciality Medicines Limited announced on August 12, 2026, that it has received regulatory approval in Ethiopia for two new CNS products, Olazyn 5 and Diazem 5. This brings its total registered formulations in Ethiopia to 12 and its global portfolio to 14, including registrations in Peru. The approvals underscore the company's ongoing strategy to expand its export presence in regulated and semi-regulated markets across Africa and Latin America.
3mo agoSpeciality Medicines FY26 net profit rises 81% to ₹1,303.29 lakh
Speciality Medicines reported an 81.1% rise in FY26 net profit to ₹1,303.29 lakh, driven by a 29.2% increase in revenue to ₹7,528.51 lakh. The Board approved audited results on May 28, 2026, confirming an unmodified opinion from auditors M/s. A K Ostwal & Co. The company utilized ₹509.15 lakh of its ₹2,914 lakh IPO proceeds, with no tax provision due to startup benefits under Section 80-IAC.
5mo agoNo similar stocks data available.
An investment of ₹10,000 made 1 year ago in Speciality Medicines is now worth
₹ 13,503.00
Giving a profit of
₹ 3,503.00 (35.03%)
Note: Past profits do not guarantee future returns.
